Publicacións nas que colabora con Isabel Castrejón (28)

2024

  1. Early identification of golimumab-treated patients with higher likelihood of long-term retention

    Frontiers in Immunology, Vol. 15

  2. Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

    Arthritis Research and Therapy, Vol. 26, Núm. 1

  3. Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Real-world data from the BIOBADASER registry

    Annals of the Rheumatic Diseases

2023

  1. Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study

    RMD open, Vol. 9, Núm. 1

  2. Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases

    Advances in Rheumatology, Vol. 63, Núm. 1

  3. Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis

    Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197

  4. Proposal for updating the Health Assessment Questionnaire

    Reumatologia Clinica, Vol. 19, Núm. 5, pp. 266-272

  5. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology

    Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81

2022

  1. Retention of golimumab treatment following discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry

    Musculoskeletal Care, Vol. 20, Núm. 2, pp. 403-407

2021

  1. Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression

    Frontiers in Medicine, Vol. 8

  2. Role of targeted therapies in rheumatic patients on COVID-19 outcomes: Results from the COVIDSER study

    RMD Open, Vol. 7, Núm. 3

2020

  1. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: A multicentric matched cohort study

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 12, pp. 1544-1549

  2. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1170-1173

2019

  1. The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity

    PLoS ONE, Vol. 14, Núm. 4

2017

  1. Corrigendum to “Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes (Seminars in Arthritis and Rheumatism (2017) 46(5) (609–614) (S0049017216303432) (10.1016/j.semarthrit.2016.10.002))

    Seminars in Arthritis and Rheumatism

  2. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes

    Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 5, pp. 609-614

2016

  1. Cut-offs and response criteria for the Hospital Universitario la Princesa Index (HUPI) and their comparison to widely-used indices of disease activity in rheumatoid arthritis

    PLoS ONE, Vol. 11, Núm. 9

2015

  1. Erratum to Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis (Rheumatol Int, (2015), 10.1007/s00296-014-3189-6)

    Rheumatology International

  2. Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis

    Rheumatology International, Vol. 35, Núm. 7, pp. 1127-1137

  3. The EULAR Outcome Measures Library: An evolutional database of validated patient-reported instruments

    Annals of the Rheumatic Diseases